INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 124 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $11,000 | -65.6% | 3,200 | 0.0% | 0.00% | – |
Q3 2018 | $32,000 | -97.9% | 3,200 | -98.2% | 0.00% | -100.0% |
Q3 2017 | $1,554,000 | -29.8% | 175,000 | 0.0% | 0.01% | -30.0% |
Q2 2017 | $2,213,000 | +68.5% | 175,000 | +40.0% | 0.01% | +66.7% |
Q1 2017 | $1,313,000 | +14.2% | 125,000 | 0.0% | 0.01% | +20.0% |
Q4 2016 | $1,150,000 | -21.9% | 125,000 | 0.0% | 0.01% | -28.6% |
Q3 2016 | $1,473,000 | -8.9% | 125,000 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $1,617,000 | -19.1% | 125,000 | 0.0% | 0.01% | -12.5% |
Q1 2016 | $1,998,000 | -83.8% | 125,000 | -70.9% | 0.01% | -85.5% |
Q4 2015 | $12,310,000 | -13.8% | 430,000 | -14.3% | 0.06% | -19.1% |
Q3 2015 | $14,275,000 | +18.0% | 501,600 | +49.0% | 0.07% | +28.3% |
Q2 2015 | $12,094,000 | -0.1% | 336,700 | +61.6% | 0.05% | 0.0% |
Q1 2015 | $12,108,000 | +2002.1% | 208,300 | +1398.6% | 0.05% | +1666.7% |
Q1 2014 | $576,000 | -14.0% | 13,900 | -19.7% | 0.00% | 0.0% |
Q4 2013 | $670,000 | +86.1% | 17,300 | +68.0% | 0.00% | +50.0% |
Q3 2013 | $360,000 | +990.9% | 10,300 | +329.2% | 0.00% | – |
Q2 2013 | $33,000 | – | 2,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 3,028,354 | $30,526,000 | 0.37% |
Engineers Gate Manager LP | 96,105 | $969,000 | 0.07% |
BOOTHBAY FUND MANAGEMENT, LLC | 61,600 | $621,000 | 0.06% |
GAM Holding AG | 83,940 | $846,000 | 0.03% |
SHELL ASSET MANAGEMENT CO | 90,282 | $910,000 | 0.02% |
SFMG, LLC | 11,994 | $107,000 | 0.02% |
QS Investors, LLC | 159,133 | $1,604,000 | 0.02% |
Winslow, Evans & Crocker, Inc. | 4,060 | $42,000 | 0.01% |
PANAGORA ASSET MANAGEMENT INC | 285,646 | $2,879,000 | 0.01% |
PEAK6 Investments LLC | 225,800 | $2,276,000 | 0.01% |